Cargando…

Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column

BACKGROUND: Enterovirus 71 (EV-71) is a neurotropic virus causing Hand, Foot and Mouth Disease (HFMD) in infants and children under the age of five. It is a major concern for public health issues across Asia-Pacific region. The most effective way to control the disease caused by EV-71 is by vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kattur Venkatachalam, Ashok Raj, Szyporta, Milene, Kiener, Tanja Kristin, Balraj, Premanand, Kwang, Jimmy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042139/ https://www.ncbi.nlm.nih.gov/pubmed/24884895 http://dx.doi.org/10.1186/1743-422X-11-99

Ejemplares similares

Development of A Sensitive and Specific Epitope-Blocking ELISA for Universal Detection of Antibodies to Human Enterovirus 71 Strains
por: He, Fang, et al.
Publicado: (2013)

Recombinant Baculovirus Associated with Bilosomes as an Oral Vaccine Candidate against HEV71 Infection in Mice
por: Premanand, Balraj, et al.
Publicado: (2013)

RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production
por: Meng, Tao, et al.
Publicado: (2012)

Characterization of an Isotype-Dependent Monoclonal Antibody against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection
por: Lim, Xiao Fang, et al.
Publicado: (2012)

Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein
por: Kiener, Tanja K, et al.
Publicado: (2012)

Display of VP1 on the Surface of Baculovirus and Its Immunogenicity against Heterologous Human Enterovirus 71 Strains in Mice
por: Meng, Tao, et al.
Publicado: (2011)

Intranasal Immunization of Baculovirus Displayed Hemagglutinin Confers Complete Protection against Mouse Adapted Highly Pathogenic H7N7 Reassortant Influenza Virus
por: Rajesh Kumar, Subaschandrabose, et al.
Publicado: (2013)

Electrospun Weak Anion-exchange Fibrous Membranes for Protein Purification
por: Chen, Shu-Ting, et al.
Publicado: (2020)

A Novel Universal Neutralizing Monoclonal Antibody against Enterovirus 71 That Targets the Highly Conserved “Knob” Region of VP3 Protein
por: Kiener, Tanja K., et al.
Publicado: (2014)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Enterovirus 71 Outbreak, Brunei
por: AbuBakar, Sazaly, et al.
Publicado: (2009)

Recombinant Human Enterovirus 71
Publicado: (2004)

The cellular receptor for enterovirus 71
por: Liu, Yue, et al.
Publicado: (2014)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Cell and tissue tropism of enterovirus 71 and other enteroviruses infections
por: Lin, Jing-Yi, et al.
Publicado: (2014)

Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge
por: kumar, Subaschandrabose Rajesh, et al.
Publicado: (2015)

COPI Is Required for Enterovirus 71 Replication
por: Wang, Jianmin, et al.
Publicado: (2012)

Seroepidemiology of Human Enterovirus 71, Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2002)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

112 The Development of Enterovirus 71 Vaccine
por: Xiuling, Li, et al.
Publicado: (2014)

Enterovirus 71 infection and neurological complications
por: Lee, Kyung Yeon
Publicado: (2016)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Cellular receptors for enterovirus A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2020)

Adaptation and Virulence of Enterovirus-A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2021)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Active yeast ribosome preparation using monolithic anion exchange chromatography
por: Munoz, Antonio M., et al.
Publicado: (2016)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Excellent Response to Plasma Exchange in Three Patients With Enterovirus-71 Neurological Disease
por: Pascual-Goñi, Elba, et al.
Publicado: (2019)

Hydrophobicity of polymer based anion-exchange columns for ion chromatography
por: Nesterenko, Pavel N., et al.
Publicado: (2021)

Sentinel surveillance for enterovirus 71, Taiwan, 1998.
por: Wu, T N, et al.
Publicado: (1999)

Enterovirus 71 Maternal Antibodies in Infants, Taiwan
por: Luo, Shu-Ting, et al.
Publicado: (2009)

Molecular Analysis of Virulent Determinants of Enterovirus 71
por: Li, Renqing, et al.
Publicado: (2011)

Enterovirus 71 Outbreaks, Taiwan: Occurrence and Recognition
por: Lin, Tzou-Yien, et al.
Publicado: (2003)

Enterovirus 71 infection: An experience in Korea, 2009
por: Kim, Kyung Hyo
Publicado: (2010)

Strategies to develop antivirals against enterovirus 71
por: Kuo, Rei-Lin, et al.
Publicado: (2013)

Human enterovirus 71 epidemics: what's next?
por: Yip, Cyril C. Y., et al.
Publicado: (2013)

Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71
por: Liao, Yu-Ting, et al.
Publicado: (2015)

Development of Novel Vaccines against Enterovirus-71
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2015)

Innate Immunity and Immune Evasion by Enterovirus 71
por: Pathinayake, Prabuddha S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t4ersravpvjhn11u2o6jpmsoll